Search Constraints
« Previous |
1 - 20 of 27
|
Next »
Search Results
Select an image to start the slideshow
A Statement
1 of 20
A Summary of the National Institutes of Health (USA) Guidelines for Recombinant DNA Research
2 of 20
Appendix C: Program of the International Conference on Recombinant DNA Molecules
3 of 20
Appendix D: Proposed Guidelines on Potential Biohazards Associated with Experiments Involving Genetically Altered Microorganisms
4 of 20
Appendix E: Preparation and Use of Recombinant Molecules Involving Animal Virus Genomes
5 of 20
Appendix E: Preparation and Use of Recombinant Molecules Involving Animal Virus Genomes
6 of 20
Appendix F: Cloned Eukaryotic DNA
7 of 20
Appendix H: Provisional Statement of the Conference Proceedings
8 of 20
Appendix I: Summary Statement of the Asilomar Conference on Recombinant DNA Molecules
9 of 20
Appendix I: Summary Statement of the Asilomar Conference on Recombinant DNA Molecules
10 of 20
Appendix I: Summary Statement of the Asilomar Conference on Recombinant DNA Molecules
11 of 20
Appendix J: A Plausible Model for Monitoring Compliance with Containment Guidelines
12 of 20
Interview with Dr. Maxine F. Singer [on recombinant DNA research and NIH]
13 of 20
Letter from Maxine Singer to Wallace P. Rowe
14 of 20
Letter from Maxine Singer to William J. Gartland
15 of 20
Letter from Roy Curtiss III to Donald S. Fredrickson
16 of 20
Letter from Roy Curtiss III to Maxine Singer
17 of 20
Letter from Stanley N. Cohen to Maxine Singer
18 of 20
Letter from Wallace P. Rowe to Maxine Singer
19 of 20
Memorandum from Allen Silverstone to the Advisory Committee on the Guidelines for Recombinant DNA
20 of 20